BIOMAT Database Logo BIOMAT Database Logo

Studies on sustained-release dosage forms. III. Preparation of nifedipine suppositories and bioavailability in rabbits. 1985

T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada

UI MeSH Term Description Entries
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
October 1987, Chemical & pharmaceutical bulletin,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
[Studies on sustained-release dosage forms for clorprenaline pamoate].
June 1982, Yao xue xue bao = Acta pharmaceutica Sinica,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Sustained-release dosage forms.
March 1990, Iowa medicine : journal of the Iowa Medical Society,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Sustained-release dosage forms.
February 1990, Iowa medicine : journal of the Iowa Medical Society,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Dissolution studies of some sustained-release theophylline dosage forms.
July 1984, Journal of pharmaceutical sciences,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Effect of food on nifedipine sustained-release preparation.
September 1989, DICP : the annals of pharmacotherapy,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
February 1990, Chemical & pharmaceutical bulletin,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
October 1987, Journal of pharmaceutical sciences,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
Dissolution studies of some regular and sustained-release dyphylline dosage forms.
January 1984, Pharmaceutica acta Helvetiae,
T Umeda, and T Yokoyama, and N Ohnishi, and T Kuroda, and Y Kita, and K Kuroda, and S Asada
[Oral dosage forms with sustained release].
February 1973, Pharmaceutisch weekblad,
Copied contents to your clipboard!